Baxter International (BAX) Revenue (2009 - 2026)

Baxter International (BAX) has reported Revenue for 18 consecutive years, with $3.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 5.34% year-over-year to $3.0 billion in Q2 2026; TTM through Jun 2026 was $11.1 billion, a 1.92% increase from a year earlier, with the FY2025 full-year figure at $11.2 billion, up 5.72% from the prior year.
• Revenue was $3.0 billion for Q2 2026 at Baxter International, up from $2.7 billion in the prior quarter.
• Over five years, Revenue peaked at $3.7 billion in Q4 2022 and troughed at $2.4 billion in Q1 2023.
• A 5-year average of $2.9 billion and a median of $2.7 billion in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 30.22% in 2022 and plunged 31.39% in 2023, its largest moves.
• Over 5 years, Revenue stood at $3.7 billion in 2022, then dropped by 27.13% to $2.7 billion in 2023, then advanced by 0.88% to $2.8 billion in 2024, then grew by 2.07% to $2.8 billion in 2025, then increased by 5.34% to $3.0 billion in 2026.
• The last three Revenue figures came in at $3.0 billion (Q2 2026), $2.7 billion (Q1 2026), and $2.8 billion (Q2 2025), per Business Quant data.